Skip to content

WHWK WHWK Change in Other Assets

Change in Other Assets at other companies

Eli Lilly logo
Eli LillyLLY
$1.65B+98.4%
Pfizer logo
PfizerPFE
-$322.25M+61.9%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-$3.03M-254%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$887K-26.2%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$228K+90.9%
Immunome logo
ImmunomeIMNM
$5.1M+199%

Other financials

Income statement

See full
Revenue--100%
Gross profit--100%
Operating income-$23.5M-54.6%
Net income-$22.2M-130%
EPS (diluted)-$0.32-117%

Balance sheet

See full
Cash & equivalents$34.8M-84.7%
Total debt$833.0K-34.3%
Total equity$116.2M-47.6%
Total assets$127.2M-45.6%

Cash flow

See full
Operating cash flow-$22.2M-87.2%
CapEx--100%
Free cash flow-$22.2M-78.9%

Valuation

See full
Market cap$226.49M+131%

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-1,601.1%-1,985pp
Net margin-288.3%+61.6pp
FCF margin-1,371.4%-1,730pp

Returns & leverage

See full
Return on equity-68.5%-86.2pp
Debt / equity0.0×
Current ratio11.4×-7.6×

Where this comes from

Reported directly by WHWK in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.

The official record: WHWK’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about WHWK's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WHWK's change in other assets?
WHWK (WHWK) reported change in other assets of -$163K in Q1 2026.
How has WHWK's change in other assets changed year-over-year?
WHWK's change in other assets decreased by 43.0% year-over-year, from -$114K to -$163K.
What is the long-term trend for WHWK's change in other assets?
Over 2 years (2021 to 2024), WHWK's change in other assets has grown at a 3.8% compound annual growth rate (CAGR), from -$481K to -$518K.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.